Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis

被引：40

作者：

Rajani, R ^{[1
]}

Smyth, J ^{[1
]}

Koffman, CG ^{[1
]}

Abbs, I ^{[1
]}

Goldsmith, DJA ^{[1
]}

机构：

[1] Guys Hosp, London, England

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2002年 / 17卷 / 12期

关键词：

D O I：

10.1093/ndt/17.12.2278

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

收藏

页码：2278 / 2280

页数：3

相关论文

共 5 条

[1]

DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14

[2]

JUNOR BJR, 1993, ADV PERIT D, V9, P187

[3]

KAHAN BD, 2001, EXPERT OPIN PHARMACO, V2, P1093

[4] Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group [J].

Nomoto, Y ;

Kawaguchi, Y ;

Kubo, H ;

Hirano, H ;

Sakai, S ;

Kurokawa, K .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (03) :420-427

[5] Sustained suppression of neointimal proliferation by sirolimus-eluting stents - One-year angiographic and intravascular ultrasound follow-up [J].

Sousa, JE ;

Costa, MA ;

Abizaid, AC ;

Rensing, BJ ;

Abizaid, AS ;

Tanajura, LF ;

Kozuma, K ;

Van Langenhove, G ;

Sousa, AGMR ;

Falotico, R ;

Jaeger, J ;

Popma, JJ ;

Serruys, PW .

CIRCULATION, 2001, 104 (17) :2007-2011